Skip to main
STXS

Stereotaxis Inc (STXS) Stock Forecast & Price Target

Stereotaxis Inc (STXS) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Stereotaxis Inc. is projected to see substantial revenue growth driven by an increase in system sales adoption and a rise in catheter utilization, with anticipated revenue streams for FY26E reaching $43 million, $12 million, and $31 million, reflecting growth rates of 24%, 20%, and 25%, respectively. The company reported a remarkable 95% year-over-year revenue increase to $8.8 million in the second quarter, alongside strong recurring revenue growth of 35% year-over-year to $5.8 million, bolstered by the successful introduction of the Map-iT and MAGiC ablation catheters. Significant regulatory achievements and the anticipated launch of the GenesisX system are expected to enhance the company’s product portfolio, leading to increased utilization and recurring revenues, which support a favorable outlook for the firm's financial performance.

Bears say

Stereotaxis Inc. is facing several significant challenges that negatively impact its financial outlook, including operating expenses of $8.6 million and a net loss of $3.8 million, highlighting ongoing financial strain. The company is hindered by delays in new product approvals, supply issues with current catheters, reimbursement changes, and growing competition from manual approaches and other robotic platforms, all of which may adversely affect revenue generation. Furthermore, with only two years of cash runway left, Stereotaxis may need to seek additional financing, raising concerns about its long-term sustainability and potential for profitability.

Stereotaxis Inc (STXS) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stereotaxis Inc (STXS) Forecast

Analysts have given Stereotaxis Inc (STXS) a Buy based on their latest research and market trends.

According to 2 analysts, Stereotaxis Inc (STXS) has a Buy consensus rating as of Jan 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stereotaxis Inc (STXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.